An inclusive solution (columns, standards, and mobile-phase concentrates) for characterizing, monitoring, and quality control testing charge variants of mAb-based therapeutics from discovery and development through manufacturing. Scientists can easily obtain desired data using defined methods on any LC platform without sacrificing performance. The benefits include: